StonvexLoading…
StonvexCore line items from LASR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-08-05 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $78.12M | $80.18M | $261.33M | $180.15M | $113.40M |
Operating Income | Not available | $-719.00K | $-26.55M | $-21.14M | $-13.85M |
Net Income | Not available | $645.00K | $-23.47M | $-18.56M | $-11.68M |
EPS (Diluted) | $0.13 | $0.01 | $-0.47 | $-0.37 | $-0.24 |
Total Assets | Not available | $515.70M | $315.21M | $298.69M | $295.25M |
Total Liabilities | Not available | $86.46M | $88.46M | $80.20M | $79.25M |
Cash & Equivalents | Not available | $298.21M | $98.70M | $81.11M | $78.81M |
Free Cash Flow OCF − CapEx | Not available | $7.57M | $12.30M | $-3.63M | $-6.08M |
Shares Outstanding | Not available | 56.41M | 51.16M | 50.78M | 49.88M |